跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA QILU 2,5 MG CÁPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA QILU 2,5 MG CÁPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA QILU 2,5 MG CÁPSULAS DURAS EFG
Qilu Pharma Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 11, 2024
Approval ID
1a0e0bafae44c135
Company
Qilu Pharma Spain S.L.
Type
Standard
Approval Details
Approval Id
1a0e0bafae44c135
Drug Cima Aemps Name
LENALIDOMIDA QILU 2,5 MG CÁPSULAS DURAS EFG
Register Number
89871
Holder Company Name
Qilu Pharma Spain S.L.
Marketing Company Name
Qilu Pharma Spain S.L.
Holder Company Detail Path
/organization/qilu-pharma-spain-sl
Marketing Company Detail Path
/organization/qilu-pharma-spain-sl
Authorization Date
2024-10-11
Dosage Form
CÁPSULA DURA
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Qilu Pharma Spain S.L.
Company Detail Path
/organization/qilu-pharma-spain-sl
Company Information
Pharmaceutical Company Name
QILU PHARMA SPAIN SL.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA, 40 - PISO 8
Active Ingredients
LENALIDOMIDA
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 11, 2024
Approval ID
1a0e0bafae44c135
Type
Standard
Back to CIMA-AEMPS Approvals
